世界の大麻ベース医薬品市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Cannabis-based Medicines Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3965 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、大麻ベース医薬品の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（CBD（カンナビジオール）ベース、THC（テトラヒドロカンナビノール）ベース、その他）、用途別市場規模（経口液剤、錠剤、パッチ、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・大麻ベース医薬品の市場動向 ・企業の競争状況、市場シェア ・大麻ベース医薬品の種類別市場規模と予測2016-2027（CBD（カンナビジオール）ベース、THC（テトラヒドロカンナビノール）ベース、その他） ・大麻ベース医薬品の用途別市場規模と予測2016-2027（経口液剤、錠剤、パッチ、その他） ・大麻ベース医薬品の北米市場規模2016-2027（アメリカ、カナダ） ・大麻ベース医薬品の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・大麻ベース医薬品のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・大麻ベース医薬品の中南米市場規模2016-2027（メキシコ、ブラジル） ・大麻ベース医薬品の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（GW Pharmaceuticals plc、INSYS Therapeutics、Aequus Pharmaceuticals、Axim Biotechnologies、Revive Therapeutics、MGC Pharmaceuticals、ECHO Pharmaceuticals） ・結論

Marijuana (medical cannabis) is used to treat nausea, pain, anxiety, MS, insomnia, epilepsy, and other conditions. Tetrahydrocannabinol (THC) and cannabidiol (CBD) are the main chemicals used in medicine. In the medicines market, Epidiolex, the first cannabis-based medication approved by the US Food and Drug Administration.

Market Analysis and Insights: Global Cannabis-based Medicines Market
The global Cannabis-based Medicines market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cannabis-based Medicines market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cannabis-based Medicines market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cannabis-based Medicines market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cannabis-based Medicines market.

Global Cannabis-based Medicines Scope and Market Size
Cannabis-based Medicines market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cannabis-based Medicines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
CBD (Cannabidiol) Based
THC (Tetrahydrocannabinol) Based
Others

Segment by Application
Oral Solution
Tablets
Patches
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
GW Pharmaceuticals plc
INSYS Therapeutics
Aequus Pharmaceuticals
Axim Biotechnologies
Revive Therapeutics
MGC Pharmaceuticals
ECHO Pharmaceuticals

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cannabis-based Medicines Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 CBD (Cannabidiol) Based
1.2.3 THC (Tetrahydrocannabinol) Based
1.2.4 Others
1.3 Market by Application
1.3.1 Global Cannabis-based Medicines Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Oral Solution
1.3.3 Tablets
1.3.4 Patches
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Cannabis-based Medicines Market Perspective (2016-2027)
2.2 Cannabis-based Medicines Growth Trends by Regions
2.2.1 Cannabis-based Medicines Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cannabis-based Medicines Historic Market Share by Regions (2016-2021)
2.2.3 Cannabis-based Medicines Forecasted Market Size by Regions (2022-2027)
2.3 Cannabis-based Medicines Industry Dynamic
2.3.1 Cannabis-based Medicines Market Trends
2.3.2 Cannabis-based Medicines Market Drivers
2.3.3 Cannabis-based Medicines Market Challenges
2.3.4 Cannabis-based Medicines Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Cannabis-based Medicines Players by Revenue
3.1.1 Global Top Cannabis-based Medicines Players by Revenue (2016-2021)
3.1.2 Global Cannabis-based Medicines Revenue Market Share by Players (2016-2021)
3.2 Global Cannabis-based Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cannabis-based Medicines Revenue
3.4 Global Cannabis-based Medicines Market Concentration Ratio
3.4.1 Global Cannabis-based Medicines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cannabis-based Medicines Revenue in 2020
3.5 Cannabis-based Medicines Key Players Head office and Area Served
3.6 Key Players Cannabis-based Medicines Product Solution and Service
3.7 Date of Enter into Cannabis-based Medicines Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Cannabis-based Medicines Breakdown Data by Type
4.1 Global Cannabis-based Medicines Historic Market Size by Type (2016-2021)
4.2 Global Cannabis-based Medicines Forecasted Market Size by Type (2022-2027)

5 Cannabis-based Medicines Breakdown Data by Application
5.1 Global Cannabis-based Medicines Historic Market Size by Application (2016-2021)
5.2 Global Cannabis-based Medicines Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Cannabis-based Medicines Market Size (2016-2027)
6.2 North America Cannabis-based Medicines Market Size by Type
6.2.1 North America Cannabis-based Medicines Market Size by Type (2016-2021)
6.2.2 North America Cannabis-based Medicines Market Size by Type (2022-2027)
6.2.3 North America Cannabis-based Medicines Market Size by Type (2016-2027)
6.3 North America Cannabis-based Medicines Market Size by Application
6.3.1 North America Cannabis-based Medicines Market Size by Application (2016-2021)
6.3.2 North America Cannabis-based Medicines Market Size by Application (2022-2027)
6.3.3 North America Cannabis-based Medicines Market Size by Application (2016-2027)
6.4 North America Cannabis-based Medicines Market Size by Country
6.4.1 North America Cannabis-based Medicines Market Size by Country (2016-2021)
6.4.2 North America Cannabis-based Medicines Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Cannabis-based Medicines Market Size (2016-2027)
7.2 Europe Cannabis-based Medicines Market Size by Type
7.2.1 Europe Cannabis-based Medicines Market Size by Type (2016-2021)
7.2.2 Europe Cannabis-based Medicines Market Size by Type (2022-2027)
7.2.3 Europe Cannabis-based Medicines Market Size by Type (2016-2027)
7.3 Europe Cannabis-based Medicines Market Size by Application
7.3.1 Europe Cannabis-based Medicines Market Size by Application (2016-2021)
7.3.2 Europe Cannabis-based Medicines Market Size by Application (2022-2027)
7.3.3 Europe Cannabis-based Medicines Market Size by Application (2016-2027)
7.4 Europe Cannabis-based Medicines Market Size by Country
7.4.1 Europe Cannabis-based Medicines Market Size by Country (2016-2021)
7.4.2 Europe Cannabis-based Medicines Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Cannabis-based Medicines Market Size (2016-2027)
8.2 Asia-Pacific Cannabis-based Medicines Market Size by Type
8.2.1 Asia-Pacific Cannabis-based Medicines Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cannabis-based Medicines Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cannabis-based Medicines Market Size by Type (2016-2027)
8.3 Asia-Pacific Cannabis-based Medicines Market Size by Application
8.3.1 Asia-Pacific Cannabis-based Medicines Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cannabis-based Medicines Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cannabis-based Medicines Market Size by Application (2016-2027)
8.4 Asia-Pacific Cannabis-based Medicines Market Size by Region
8.4.1 Asia-Pacific Cannabis-based Medicines Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cannabis-based Medicines Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Cannabis-based Medicines Market Size (2016-2027)
9.2 Latin America Cannabis-based Medicines Market Size by Type
9.2.1 Latin America Cannabis-based Medicines Market Size by Type (2016-2021)
9.2.2 Latin America Cannabis-based Medicines Market Size by Type (2022-2027)
9.2.3 Latin America Cannabis-based Medicines Market Size by Type (2016-2027)
9.3 Latin America Cannabis-based Medicines Market Size by Application
9.3.1 Latin America Cannabis-based Medicines Market Size by Application (2016-2021)
9.3.2 Latin America Cannabis-based Medicines Market Size by Application (2022-2027)
9.3.3 Latin America Cannabis-based Medicines Market Size by Application (2016-2027)
9.4 Latin America Cannabis-based Medicines Market Size by Country
9.4.1 Latin America Cannabis-based Medicines Market Size by Country (2016-2021)
9.4.2 Latin America Cannabis-based Medicines Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Cannabis-based Medicines Market Size (2016-2027)
10.2 Middle East & Africa Cannabis-based Medicines Market Size by Type
10.2.1 Middle East & Africa Cannabis-based Medicines Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cannabis-based Medicines Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cannabis-based Medicines Market Size by Type (2016-2027)
10.3 Middle East & Africa Cannabis-based Medicines Market Size by Application
10.3.1 Middle East & Africa Cannabis-based Medicines Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cannabis-based Medicines Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cannabis-based Medicines Market Size by Application (2016-2027)
10.4 Middle East & Africa Cannabis-based Medicines Market Size by Country
10.4.1 Middle East & Africa Cannabis-based Medicines Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cannabis-based Medicines Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 GW Pharmaceuticals plc
11.1.1 GW Pharmaceuticals plc Company Details
11.1.2 GW Pharmaceuticals plc Business Overview
11.1.3 GW Pharmaceuticals plc Cannabis-based Medicines Introduction
11.1.4 GW Pharmaceuticals plc Revenue in Cannabis-based Medicines Business (2016-2021)
11.1.5 GW Pharmaceuticals plc Recent Development
11.2 INSYS Therapeutics
11.2.1 INSYS Therapeutics Company Details
11.2.2 INSYS Therapeutics Business Overview
11.2.3 INSYS Therapeutics Cannabis-based Medicines Introduction
11.2.4 INSYS Therapeutics Revenue in Cannabis-based Medicines Business (2016-2021)
11.2.5 INSYS Therapeutics Recent Development
11.3 Aequus Pharmaceuticals
11.3.1 Aequus Pharmaceuticals Company Details
11.3.2 Aequus Pharmaceuticals Business Overview
11.3.3 Aequus Pharmaceuticals Cannabis-based Medicines Introduction
11.3.4 Aequus Pharmaceuticals Revenue in Cannabis-based Medicines Business (2016-2021)
11.3.5 Aequus Pharmaceuticals Recent Development
11.4 Axim Biotechnologies
11.4.1 Axim Biotechnologies Company Details
11.4.2 Axim Biotechnologies Business Overview
11.4.3 Axim Biotechnologies Cannabis-based Medicines Introduction
11.4.4 Axim Biotechnologies Revenue in Cannabis-based Medicines Business (2016-2021)
11.4.5 Axim Biotechnologies Recent Development
11.5 Revive Therapeutics
11.5.1 Revive Therapeutics Company Details
11.5.2 Revive Therapeutics Business Overview
11.5.3 Revive Therapeutics Cannabis-based Medicines Introduction
11.5.4 Revive Therapeutics Revenue in Cannabis-based Medicines Business (2016-2021)
11.5.5 Revive Therapeutics Recent Development
11.6 MGC Pharmaceuticals
11.6.1 MGC Pharmaceuticals Company Details
11.6.2 MGC Pharmaceuticals Business Overview
11.6.3 MGC Pharmaceuticals Cannabis-based Medicines Introduction
11.6.4 MGC Pharmaceuticals Revenue in Cannabis-based Medicines Business (2016-2021)
11.6.5 MGC Pharmaceuticals Recent Development
11.7 ECHO Pharmaceuticals
11.7.1 ECHO Pharmaceuticals Company Details
11.7.2 ECHO Pharmaceuticals Business Overview
11.7.3 ECHO Pharmaceuticals Cannabis-based Medicines Introduction
11.7.4 ECHO Pharmaceuticals Revenue in Cannabis-based Medicines Business (2016-2021)
11.7.5 ECHO Pharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Cannabis-based Medicines Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of CBD (Cannabidiol) Based
Table 3. Key Players of THC (Tetrahydrocannabinol) Based
Table 4. Key Players of Others
Table 5. Global Cannabis-based Medicines Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Cannabis-based Medicines Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Cannabis-based Medicines Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Cannabis-based Medicines Market Share by Regions (2016-2021)
Table 9. Global Cannabis-based Medicines Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Cannabis-based Medicines Market Share by Regions (2022-2027)
Table 11. Cannabis-based Medicines Market Trends
Table 12. Cannabis-based Medicines Market Drivers
Table 13. Cannabis-based Medicines Market Challenges
Table 14. Cannabis-based Medicines Market Restraints
Table 15. Global Cannabis-based Medicines Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Cannabis-based Medicines Market Share by Players (2016-2021)
Table 17. Global Top Cannabis-based Medicines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cannabis-based Medicines as of 2020)
Table 18. Ranking of Global Top Cannabis-based Medicines Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Cannabis-based Medicines Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Cannabis-based Medicines Product Solution and Service
Table 22. Date of Enter into Cannabis-based Medicines Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Cannabis-based Medicines Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Cannabis-based Medicines Revenue Market Share by Type (2016-2021)
Table 26. Global Cannabis-based Medicines Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Cannabis-based Medicines Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Cannabis-based Medicines Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Cannabis-based Medicines Revenue Market Share by Application (2016-2021)
Table 30. Global Cannabis-based Medicines Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Cannabis-based Medicines Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Cannabis-based Medicines Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Cannabis-based Medicines Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Cannabis-based Medicines Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Cannabis-based Medicines Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Cannabis-based Medicines Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Cannabis-based Medicines Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Cannabis-based Medicines Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Cannabis-based Medicines Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Cannabis-based Medicines Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Cannabis-based Medicines Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Cannabis-based Medicines Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Cannabis-based Medicines Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Cannabis-based Medicines Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Cannabis-based Medicines Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Cannabis-based Medicines Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Cannabis-based Medicines Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Cannabis-based Medicines Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Cannabis-based Medicines Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Cannabis-based Medicines Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Cannabis-based Medicines Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Cannabis-based Medicines Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Cannabis-based Medicines Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Cannabis-based Medicines Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Cannabis-based Medicines Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Cannabis-based Medicines Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Cannabis-based Medicines Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Cannabis-based Medicines Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Cannabis-based Medicines Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Cannabis-based Medicines Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Cannabis-based Medicines Market Size by Country (2022-2027) & (US$ Million)
Table 62. GW Pharmaceuticals plc Company Details
Table 63. GW Pharmaceuticals plc Business Overview
Table 64. GW Pharmaceuticals plc Cannabis-based Medicines Product
Table 65. GW Pharmaceuticals plc Revenue in Cannabis-based Medicines Business (2016-2021) & (US$ Million)
Table 66. GW Pharmaceuticals plc Recent Development
Table 67. INSYS Therapeutics Company Details
Table 68. INSYS Therapeutics Business Overview
Table 69. INSYS Therapeutics Cannabis-based Medicines Product
Table 70. INSYS Therapeutics Revenue in Cannabis-based Medicines Business (2016-2021) & (US$ Million)
Table 71. INSYS Therapeutics Recent Development
Table 72. Aequus Pharmaceuticals Company Details
Table 73. Aequus Pharmaceuticals Business Overview
Table 74. Aequus Pharmaceuticals Cannabis-based Medicines Product
Table 75. Aequus Pharmaceuticals Revenue in Cannabis-based Medicines Business (2016-2021) & (US$ Million)
Table 76. Aequus Pharmaceuticals Recent Development
Table 77. Axim Biotechnologies Company Details
Table 78. Axim Biotechnologies Business Overview
Table 79. Axim Biotechnologies Cannabis-based Medicines Product
Table 80. Axim Biotechnologies Revenue in Cannabis-based Medicines Business (2016-2021) & (US$ Million)
Table 81. Axim Biotechnologies Recent Development
Table 82. Revive Therapeutics Company Details
Table 83. Revive Therapeutics Business Overview
Table 84. Revive Therapeutics Cannabis-based Medicines Product
Table 85. Revive Therapeutics Revenue in Cannabis-based Medicines Business (2016-2021) & (US$ Million)
Table 86. Revive Therapeutics Recent Development
Table 87. MGC Pharmaceuticals Company Details
Table 88. MGC Pharmaceuticals Business Overview
Table 89. MGC Pharmaceuticals Cannabis-based Medicines Product
Table 90. MGC Pharmaceuticals Revenue in Cannabis-based Medicines Business (2016-2021) & (US$ Million)
Table 91. MGC Pharmaceuticals Recent Development
Table 92. ECHO Pharmaceuticals Company Details
Table 93. ECHO Pharmaceuticals Business Overview
Table 94. ECHO Pharmaceuticals Cannabis-based Medicines Product
Table 95. ECHO Pharmaceuticals Revenue in Cannabis-based Medicines Business (2016-2021) & (US$ Million)
Table 96. ECHO Pharmaceuticals Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cannabis-based Medicines Market Share by Type: 2020 VS 2027
Figure 2. CBD (Cannabidiol) Based Features
Figure 3. THC (Tetrahydrocannabinol) Based Features
Figure 4. Others Features
Figure 5. Global Cannabis-based Medicines Market Share by Application: 2020 VS 2027
Figure 6. Oral Solution Case Studies
Figure 7. Tablets Case Studies
Figure 8. Patches Case Studies
Figure 9. Others Case Studies
Figure 10. Cannabis-based Medicines Report Years Considered
Figure 11. Global Cannabis-based Medicines Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Cannabis-based Medicines Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Cannabis-based Medicines Market Share by Regions: 2020 VS 2027
Figure 14. Global Cannabis-based Medicines Market Share by Regions (2022-2027)
Figure 15. Global Cannabis-based Medicines Market Share by Players in 2020
Figure 16. Global Top Cannabis-based Medicines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cannabis-based Medicines as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Cannabis-based Medicines Revenue in 2020
Figure 18. Global Cannabis-based Medicines Revenue Market Share by Type (2016-2021)
Figure 19. Global Cannabis-based Medicines Revenue Market Share by Type (2022-2027)
Figure 20. North America Cannabis-based Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Cannabis-based Medicines Market Share by Type (2016-2027)
Figure 22. North America Cannabis-based Medicines Market Share by Application (2016-2027)
Figure 23. North America Cannabis-based Medicines Market Share by Country (2016-2027)
Figure 24. United States Cannabis-based Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Cannabis-based Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Cannabis-based Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Cannabis-based Medicines Market Share by Type (2016-2027)
Figure 28. Europe Cannabis-based Medicines Market Share by Application (2016-2027)
Figure 29. Europe Cannabis-based Medicines Market Share by Country (2016-2027)
Figure 30. Germany Cannabis-based Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Cannabis-based Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Cannabis-based Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Cannabis-based Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Cannabis-based Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Cannabis-based Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Cannabis-based Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Cannabis-based Medicines Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Cannabis-based Medicines Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Cannabis-based Medicines Market Share by Region (2016-2027)
Figure 40. China Cannabis-based Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Cannabis-based Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Cannabis-based Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Cannabis-based Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Cannabis-based Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Cannabis-based Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Cannabis-based Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Cannabis-based Medicines Market Share by Type (2016-2027)
Figure 48. Latin America Cannabis-based Medicines Market Share by Application (2016-2027)
Figure 49. Latin America Cannabis-based Medicines Market Share by Country (2016-2027)
Figure 50. Mexico Cannabis-based Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Cannabis-based Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Cannabis-based Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Cannabis-based Medicines Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Cannabis-based Medicines Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Cannabis-based Medicines Market Share by Country (2016-2027)
Figure 56. Turkey Cannabis-based Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Cannabis-based Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Cannabis-based Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. GW Pharmaceuticals plc Revenue Growth Rate in Cannabis-based Medicines Business (2016-2021)
Figure 60. INSYS Therapeutics Revenue Growth Rate in Cannabis-based Medicines Business (2016-2021)
Figure 61. Aequus Pharmaceuticals Revenue Growth Rate in Cannabis-based Medicines Business (2016-2021)
Figure 62. Axim Biotechnologies Revenue Growth Rate in Cannabis-based Medicines Business (2016-2021)
Figure 63. Revive Therapeutics Revenue Growth Rate in Cannabis-based Medicines Business (2016-2021)
Figure 64. MGC Pharmaceuticals Revenue Growth Rate in Cannabis-based Medicines Business (2016-2021)
Figure 65. ECHO Pharmaceuticals Revenue Growth Rate in Cannabis-based Medicines Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

---